Amag Pharmaceuticals to buy Cord Blood Registry
Advertisement
Amag Pharmaceuticals announced on Monday that it plans to buy Cord Blood Registry. The privately owned stem cell bank is being purchased for a whopping $700 million.
CBR houses preserves umblical cord blood and tissue sections. According to a statement released by Amag, it currently houses more than 6,00,000 units, a considerable fraction of all units in US.
The majority of Amag Pharmaceuticals' profits come from Makena, a drug used to reduce risk of premature delivery in pregnant women. It is also involved in producing medication used in oncology and patients of anemia.
The pharmaceutical company is optimistic about its prospects. It predicts immediate profits from CBR.
Amag Pharmaceuticals primarily makes, Feraheme (Ferumoxytol) used to treat iron deficiency anaemia and CKD.
CBR houses preserves umblical cord blood and tissue sections. According to a statement released by Amag, it currently houses more than 6,00,000 units, a considerable fraction of all units in US.
The majority of Amag Pharmaceuticals' profits come from Makena, a drug used to reduce risk of premature delivery in pregnant women. It is also involved in producing medication used in oncology and patients of anemia.
The pharmaceutical company is optimistic about its prospects. It predicts immediate profits from CBR.
Amag Pharmaceuticals primarily makes, Feraheme (Ferumoxytol) used to treat iron deficiency anaemia and CKD.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.